Free Trial

Scienture (SCNX) News Today

$8.05
+0.65 (+8.78%)
(As of 12:02 PM ET)
No headlines for this company have been tracked by MarketBeat.com
Get Scienture News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCNX and its competitors with MarketBeat's FREE daily newsletter.

The gold trades I'm making right now (Ad)

Back in November, gold made a tiny move of 1.6%. But using a special type of gold trade, I saw a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there were smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period.

It's all about catching what I call "Acceleration Cycles."

SCNX Media Mentions By Week

SCNX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SCNX
News Sentiment

1.89

0.67

Average
Medical
News Sentiment

SCNX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SCNX Articles
This Week

1

0

SCNX Articles
Average Week

Get Scienture News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCNX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:SCNX) was last updated on 10/28/2024 by MarketBeat.com Staff
From Our Partners